Nanosuspension: Formulation, charcterization and evaluation

International Journal of Pharma and Bio Sciences

Volumn 1, Issue 2, 2010, Pages

  Pandey, Shivanand ^a   Devmurari, Viral ^a   Goyani, Manish ^a   Ashapuri, Hetal ^a  

^a Smt R B Patel Mahila Pharmacy College Atkot   (India)

Author keywords

Disperse system; Lyophilized; Micro particles; Microparticles; Nanosuspension; Solid in semisolid; Sustained release; Sustained release Nanosuspension

Indexed keywords

COSURFACTANT; DRUG ADDITIVE; NANOCRYSTAL; ORGANIC SOLVENT; STABILIZING AGENT;

ARTICLE; CRYSTALLIZATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; GRINDING; MICROEMULSION; NANOSUSPENSION; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRECIPITATION; SOLVENT EFFECT; SUSPENSION; ZETA POTENTIAL;

EID: 80755173107     PISSN: None     EISSN: 09756299     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. RH Müller, C Jacobs and O Kayer. anosuspensions for the formulation of poorly soluble drugs. In: F Nielloud, G Marti-Mestres (ed). Pharmaceutical emulsion and suspension. New York, Marcel Dekker, 2000, p. 383-407.
2. RA Nash. Suspensions. In: J Swarbrick, JC Boylan (ed). Encyclopedia of pharmaceutical technology. Second edition vol. 3. New York, Marcel dekker,2002, p. 2045-3032.
3. RH Müller and K Peters. Nanosuspensions for the formulation of poorly soluble drug I: Preparation by size reduction technique. Int. J. Pharm. 1998; 160, 229-37.
4. VB Patravale, AA Date and RM Kulkarni. Nanosuspension: a promising drug delivery strategy. J. Pharm. Pharmacol.; 56, 827-40. 2004
5. A Wongmekiat, Y Tozuka, T Oguchi and K Yamamoto. Formation of fine drug particles by co-grinding with cyclodextrin. I. the use of β-cyclodextrin anhydrate and hydrate. Pharm. Res.; 19, 1867-72. 2002
6. K Itoh, A Pongpeerapat, Y Tozuka, T Oguchi and K Yamamoto. Nanoparticle formation of poorly water soluble drugs from ternary ground mixtures with PVP and SDS. Chem. Pharm. Bull.; 51, 171-4. 2003
7. P Mura, M Cirri, MT Faucci, JM Ginès-Dorado and GP Bettinetti. Investigation of the effects of grinding and co-grinding on physicochemical properties of glisentide. J. Pharm Biomed. Anal.; 30, 227-37. 2002
8. M Sugimoto, T Okagaki, S Narisawa, Y Koida and K Nakajima. Improvement of dissolution characteristics and bioavailability of poorly water-soluble drugs by novel co-grinding method using water soluble polymer. Int. J. Pharm.; 160, 11-9. 1998
9. T Watanabe, I Ohno, N Wakiyama, A Kusai and M Senna. Stabilization of amorphous indomethacin by co-grinding in a ternary mixture. Int. J. Pharm.; 241, 103-11,2002..
10. Eccleston, G. M. Microemulsions. In: Swarbrick, S., Boylan, J. C. (eds) Encyclopedia of pharmaceutical technology. Vol. 9, Marcel Dekker, New York, pp 375- 421(1992)
11. Kawakami, K., Yoshikawa, T. Microemulsion formulation for enhanced absorption of poorly soluble drugs I. Prescription design. J. Control. Release 81: 65-74, (2002)
12. Kim, C. K., Gao Gao, Z., Choia, H. G., Shin, H. J., Park, K. M., Lim, S. J., Hwang, K. J. Physicochemical characterization and evaluation of a microemulsion system for oral delivery of cyclosporin A. Int. J. Pharm. 161: 75-86, (1998)
13. Peters, K., Müller, R. H., Borner, K., Hahn, H., Leitz, K. S., Diederichs, J. E., Ehlers, S. Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection. J. Antimicrob. Chemother. 45: 77- 83, (2000)
14. Z Zili, S Sfar and H Fessi. Preparation and characterization of poly-ε- carprolactone nanoparticles containing griseofulvin. Int. J. Pharm. 294, 261-7. 2005;
15. X Zhang, Q Xia and N Gu. Preparation of alltrans retinoic acid nanosuspensions using a modified precipitation method. Drug. Dev. Ind. Pharm. 2006; 32, 857-63.US Patent 6,607,784 2003.
16. Gasco, M. R. Solid lipid nanospheres form warm microemulsions. Pharm. Technol. Eur. 9: 32-42, (1997)
17. Rades, T., Davies N., Watnasirichaikul, S., Tucker, I. Effects of formulation variables on characteristics of poly (ethylcyanoacrylates) nanocapsules prepared from w/o microemulsions. Int. J. Pharm. 235: 237-246, (2002).
18. JE Kipp, JCT Wong, MJ Doty and CL Rebbeck. Microprecipitation method for preparing submicron suspensions.. J. Control. Release, 45, 123, 2004
19. Trotta, M., Gallarate, M., Pattarino, F., Morel, S. Emulsions containing partially water miscible solvents for the preparation of drug nanosuspensions. J. Control. Release 76: 119- 128, (2001)
20. JE Kipp, JCT Wong, MJ Doty and CL Rebbeck. Microprecipitation method for preparing submicron suspensions.. Int. J. Pharm.; 261-7. 2007
21. Z Zili, S Sfar and H Fessi. Preparation and characterization of poly-ε- carprolactone nanoparticles containing griseofulvin. Int. J. Pharm.; 294, 261-7. 2005
22. Jahnke, S. The theory of high-pressure homogenization. In: Müller, R. H., Benita, S., Böhm, B. H. L. (eds) Emulsions and nanosuspensions for the formulation of poorly soluble drugs. Medpharm Scientific Publishers, Stuttgart, pp 177-200, (1998)
23. Müller, B. W., Müller, R. H. Particle size analysis of latex suspensions and microemulsions by photon correlation spectroscopy. J. Pharm. Sci. 73: 915-918, (1984)
24. Müller, R. H., Böhm, B. H. L. Nanosuspensions. In: Müller, R. H., Benita, S., Böhm, B. H. L. (eds) Emulsions and nanosuspensions for the formulation of poorly soluble drugs. Medpharm Scientific Publishers, Stuttgart, pp 149-174, (1998)
25. Müller, R. H., Grau, M. J. Increase of dissolution velocity and solubility of poorly water soluble drugs as nanosuspension. Proceedings, World Meeting APGI/APV, Paris. Vol. 2, pp 623-624, (1998)
26. Wallis, K. H., Müller, R. H. Determination of the surface hydrophobicity of colloidal dispersions by mini-hydrophobic interaction chromatography. Pharm. Ind. 55: 1124-1128, (1993)
27. Müller, R. H., Jacobs, C. Production and characterization of a budesonide nanosuspension for pulmonary administration. Pharm. Res. 19: 189-194, (2002)
28. B Rainbow, J Kipp, P Papadopoulos, J Wong, J Glosson, J Gass, C-S Sun, T Wielgos, R White, C Cook, K Barker and K Wood. Itraconazole IV nanosuspension enhances efficacy through altered pharmacokinetic in the rat. Int. J. Pharm.; 339, 251-60. 2007
29. R.H.Muller, B.H.L.Bohm and .J.Grau. Nanosuspensions: a formulation approach for poorly soluble and poorly bioavailable drugs. In D.Wise (Ed.) Handbook of pharmaceutical controlled release technology.;345-357. 2000
30. R.H.Muller, C.Jacobs, O. Kayser. Nanosuspensions as particulate drug formulations in therapy Rationale for development and what we can expect for the future. Ad.Drug.Del.Rev.;47:3-19, 2001